Literature DB >> 10197446

Phosphorylation-dependent protein kinase D activation.

R T Waldron1, T Iglesias, E Rozengurt.   

Abstract

The novel mouse serine-threonine kinase protein kinase D (PKD) is activated in intact Swiss 3T3 cells stimulated by phorbol esters, cell permeant diacylglycerols, bryostatin, neuropeptides and growth factors via a phosphorylation-dependent mechanism requiring protein kinase C (PKC) activity. Structural comparison of the PKD catalytic domain with other kinases reveals a close similarity with MEK family kinases, which are activated upon phosphorylation of key serine and threonine residues in a region termed the activation loop. To study the regulation of PKD, we transfected mutant PKD cDNAs in which putative activation loop serine residues 744 and 748 were mutated to either alanine or glutamic acid into COS-7 cells. Replacement of serines 744 and 748 with alanine prevented activation of the overexpressed PKD form upon phorbol ester treatment of cells, whereas replacement with glutamic acid results in full constitutive activation. Single serine to glutamic acid replacement mutants were partially activated. In vivo 32P-labeling and two-dimensional phosphopeptide mapping of PKD and catalytically inactive PKD mutants at serine 744, 748 or at both residues revealed that phorbol ester-sensitive phosphopeptides could be selectively eliminated from patterns observed as a result of these mutations. Treatment of cells with the PKC inhibitor GFI also prevented the appearance of phosphopeptide spots occuring in response to phorbol ester stimulation. These results provide direct evidence that PKD becomes activated in vivo as a consequence of PKC-mediated phosphorylation of serines 744 and 748. These results support our view of PKD as an important clement in PKC signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197446     DOI: 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  20 in total

Review 1.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

2.  Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.

Authors:  Courtney R LaValle; Liyong Zhang; Shuping Xu; Julie L Eiseman; Q Jane Wang
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

3.  Protein kinase C and Src family kinases mediate angiotensin II-induced protein kinase D activation and acute aldosterone production.

Authors:  Lawrence O Olala; Brian A Shapiro; Todd C Merchen; James J Wynn; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2014-05-22       Impact factor: 4.102

4.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

5.  PKD3 deficiency causes alterations in microtubule dynamics during the cell cycle.

Authors:  Tianzhou Zhang; Ursula Braun; Michael Leitges
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

6.  Prostaglandin F2alpha-activated protein kinase Calpha phosphorylates myristoylated alanine-rich C kinase substrate protein in bovine luteal cells.

Authors:  U Salli; F Stormshak
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

7.  Diacylglycerol kinase and phospholipase D inhibitors alter the cellular lipidome and endosomal sorting towards the Golgi apparatus.

Authors:  Anne Berit Dyve Lingelem; Simona Kavaliauskiene; Ruth Halsne; Tove Irene Klokk; Michal A Surma; Christian Klose; Tore Skotland; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2020-05-23       Impact factor: 9.261

8.  Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1.

Authors:  Catherine F Cowell; Irene K Yan; Tim Eiseler; Amanda C Leightner; Heike Döppler; Peter Storz
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

9.  PKD prevents H2O2-induced apoptosis via NF-kappaB and p38 MAPK in RIE-1 cells.

Authors:  Jun Song; Jing Li; Jingbo Qiao; Sunil Jain; B Mark Evers; Dai H Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-12-04       Impact factor: 3.575

10.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.